172 related articles for article (PubMed ID: 19026571)
1. Unresolved issues in myocardial reperfusion injury.
Buja LM; Weerasinghe P
Cardiovasc Pathol; 2010; 19(1):29-35. PubMed ID: 19026571
[TBL] [Abstract][Full Text] [Related]
2. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
3. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.
Hausenloy DJ; Tsang A; Yellon DM
Trends Cardiovasc Med; 2005 Feb; 15(2):69-75. PubMed ID: 15885573
[TBL] [Abstract][Full Text] [Related]
4. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury.
Vinten-Johansen J; Zhao ZQ; Zatta AJ; Kin H; Halkos ME; Kerendi F
Basic Res Cardiol; 2005 Jul; 100(4):295-310. PubMed ID: 15793629
[TBL] [Abstract][Full Text] [Related]
5. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
[TBL] [Abstract][Full Text] [Related]
6. Myocardial ischemia and reperfusion injury.
Buja LM
Cardiovasc Pathol; 2005; 14(4):170-5. PubMed ID: 16009313
[TBL] [Abstract][Full Text] [Related]
7. Lethal myocardial reperfusion injury: a necessary evil?
Ibanez B; Fuster V; Jiménez-Borreguero J; Badimon JJ
Int J Cardiol; 2011 Aug; 151(1):3-11. PubMed ID: 21093938
[TBL] [Abstract][Full Text] [Related]
8. Preconditioning and postconditioning: united at reperfusion.
Hausenloy DJ; Yellon DM
Pharmacol Ther; 2007 Nov; 116(2):173-91. PubMed ID: 17681609
[TBL] [Abstract][Full Text] [Related]
9. Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway.
Rajesh KG; Suzuki R; Maeda H; Yamamoto M; Yutong X; Sasaguri S
J Mol Cell Cardiol; 2005 Nov; 39(5):766-76. PubMed ID: 16171810
[TBL] [Abstract][Full Text] [Related]
10. Commentary on selected aspects of cardioprotection.
Jennings RB
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):340-8. PubMed ID: 21821537
[TBL] [Abstract][Full Text] [Related]
11. Realizing the clinical potential of ischemic preconditioning and postconditioning.
Yellon DM; Hausenloy DJ
Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
[TBL] [Abstract][Full Text] [Related]
12. Postconditioning: from the bench to bedside.
Cour M; Gomez L; Mewton N; Ovize M; Argaud L
J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):117-30. PubMed ID: 20938041
[TBL] [Abstract][Full Text] [Related]
13. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.
Davidson SM; Hausenloy D; Duchen MR; Yellon DM
Int J Biochem Cell Biol; 2006 Mar; 38(3):414-9. PubMed ID: 16280253
[TBL] [Abstract][Full Text] [Related]
14. The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion.
Garcia-Dorado D; Rodriguez-Sinovas A; Ruiz-Meana M; Inserte J; Agulló L; Cabestrero A
Cardiovasc Res; 2006 May; 70(2):274-85. PubMed ID: 16635642
[TBL] [Abstract][Full Text] [Related]
15. Postconditioning: reduction of reperfusion-induced injury.
Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 2006 May; 70(2):200-11. PubMed ID: 16545349
[TBL] [Abstract][Full Text] [Related]
16. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.
Vinten-Johansen J
Cardiovasc Res; 2004 Feb; 61(3):481-97. PubMed ID: 14962479
[TBL] [Abstract][Full Text] [Related]
17. Signalling pathways in ischaemic postconditioning.
Hausenloy DJ
Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
[TBL] [Abstract][Full Text] [Related]
18. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
19. Postconditioning prevents reperfusion injury by activating delta-opioid receptors.
Jang Y; Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z
Anesthesiology; 2008 Feb; 108(2):243-50. PubMed ID: 18212569
[TBL] [Abstract][Full Text] [Related]
20. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
